Cited by 476Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

Open access

Morris, John C., Roe, Catherine M., Grant, Elizabeth A., Head, Denise, Storandt, Martha, Goate, Alison M., Fagan, Anne M., Holtzman, David M., Mintun, Mark A.·2009·Archives of Neurology

DOI 10.1001/archneurol.2009.269PMC PMC2798814

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To determine whether preclinical Alzheimer disease (AD), as detected by the amyloid-imaging agent Pittsburgh Compound B (PiB) in cognitively normal older adults, is associated with risk of symptomatic AD. DESIGN: A longitudinal cohort study of cognitively normal older adults assessed with positron emission tomography (PET) to determine the mean cortical binding potential for PiB and followed up with annual clinical and cognitive assessments for progression to very mild dementia of the Alzheimer type (DAT). SETTING: The Alzheimer's Disease Research Center, Washington University, St Louis, Missouri. PARTICIPANTS: One hundred fifty-nine participants with a mean age of 71.5 years with a Clinical Dementia Rating (CDR) of 0 on a PET PiB scan at baseline. MAIN OUTCOME MEASURE: Progression from CDR 0 to CDR 0.5 status (very mild dementia). RESULTS: Twenty-three participants progressed to CDR 0.5 at follow-up assessment (range, 1-5 assessments after PET PiB). Of these, 9 also were diagnosed with DAT. Higher mean cortical binding potential values for PiB (hazard ratio, 4.85; 95% confidence interval, 1.22-19.01; P = .02) and age (hazard ratio, 1.14; 95% confidence interval, 1.02-1.28; P = .03) predicted progression to CDR 0.5 DAT. The CDR 0.5 DAT group showed decline in 3 cognitive domains (episodic memory, semantic memory, and visuospatial performance) and had volume loss in the parahippocampal gyrus (includes entorhinal cortex) compared with individuals who remained at CDR 0. CONCLUSION: Preclinical AD as detected by PET PiB is not benign, as it is associated with progression to symptomatic AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/archneurol.2009.269

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citation
Co-planar stereotaxic atlas of the human brain : 3-dimensional proportional system : an approach to cerebral imaging
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Self-citation
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G., Ding, Y., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,515

Show all 57 references

Sorted by citations

Items 201–300 of 469

Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
Bales, K. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.005 · Cited by 58
Neurologic Applications of PET/MR Imaging
Miller‐Thomas, M. M., & Benzinger, T. L. S. (2017) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2016.12.003 · Cited by 54
Amyloid Burden in Cognitively Normal Elderly is Associated with Preferential Hippocampal Subfield Volume Loss
Hsu, P. J., Shou, H., Benzinger, T. L. S., Marcus, D., Durbin, T. J., Morris, J. C., & Sheline, Y. I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141743 · Cited by 53
Self-citation
Amyloid imaging and cognitive decline in nondemented oldest‐old: The 90+ Study
Kawas, C. H., Greenia, D., Bullain, S., Clark, C. M., Pontecorvo, M. J., Joshi, A. D., & Corrada, M. M. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.06.005 · Cited by 51
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD
Mosconi, L., Murray, J., Tsui, W. H., Li, Y., Spector, N. C., Goldowsky, A. M., Williams, S., Osorio, R. S., McHugh, P. F., Glodzik, L., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000181 · Cited by 51
“Aducanumab” making a comeback in Alzheimer’s disease: An old wine in a new bottle
Behl, T., Kaur, I., Sehgal, A., Singh, S., Sharma, N., Makeen, H. A., Albratty, M., Alhazmi, H. A., Felemban, S. G., Alsubayiel, A. M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112746 · Cited by 50
Why have we Failed to Cure Alzheimer's Disease?
Korczyn, A. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110359 · Cited by 55
How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.
Au, R., Piers, R. J., & Devine, S. (2017) · Neuropsychology · doi:10.1037/neu0000411 · Cited by 53
Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory
Han, J. W., Maillard, P., Harvey, D., Fletcher, E., Martinez, O., Johnson, D. K., Olichney, J. M., Farias, S. T., Villeneuve, S., Jagust, W., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010531 · Cited by 49
Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
Perrin, R. J., Payton, J. E., Malone, J. P., Erdmann-Gilmore, P., Davis, A., Xiong, C., Fagan, A. M., Townsend, R. R., & Holtzman, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064314 · Cited by 50
Self-citation
PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
Pontecorvo, M. J., & Mintun, M. A. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt70 · Cited by 49
Self-citation
Neuroimaging biomarkers in Alzheimer’s disease and other dementias
Villemagne, V. L., & Chételat, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.004 · Cited by 55
A Naturalistic Study of Driving Behavior in Older Adults and Preclinical Alzheimer Disease: A Pilot Study
Babulal, G. M., Stout, S. H., Benzinger, T. L. S., Ott, B. R., Carr, D. B., Webb, M. M., Traub, C. M., Addison, A., Morris, J. C., Warren, D. K., et al. (2017) · Journal of Applied Gerontology · doi:10.1177/0733464817690679 · Cited by 48
Self-citation
Advances in Brain Amyloid Imaging
Krishnadas, N., Villemagne, V. L., Doré, V., & Rowe, C. C. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.005 · Cited by 48
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Preclinical Alzheimer’s disease biomarkers accurately predict cognitive and neuropathological outcomes
Long, J. M., Coble, D. W., Xiong, C., Schindler, S. E., Perrin, R. J., Gordon, B. A., Benzinger, T. L. S., Grant, E., Fagan, A. M., Harari, O., et al. (2022) · Brain · doi:10.1093/brain/awac250 · Cited by 49
Self-citation
Genome‐wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology
Nho, K. T., Nudelman, K. N. H., Allen, M., Hodges, A., Kim, S., Risacher, S. L., Apostolova, L. G., Lin, K., Lunnon, K., Wang, X., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12092 · Cited by 48
Back to the future: Alzheimer's disease heterogeneity revisited
Au, R., Piers, R. J., & Lancashire, L. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.006 · Cited by 45
Is Verbal Episodic Memory in Elderly with Amyloid Deposits Preserved Through Altered Neuronal Function?
Ossenkoppele, R., Madison, C. M., Oh, H., Wirth, M., van Berckel, B. N. M., & Jagust, W. J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht076 · Cited by 45
Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
Andrews, K. A., Marc Modat, A., Macdonald, K. E., Yeatman, T., Cardoso, M. J., Leung, K. K., Barnes, J., Villemagne, V. L., Rowe, C. C., Fox, N. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058816 · Cited by 48
Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
Audrain, M., Fol, R. R., Dutar, P., Potier, B., Billard, J., Flament, J., Alves, S., Burlot, M., Dufayet‐Chaffaud, G., Bemelmans, A., et al. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0070-y · Cited by 44
What can imaging tell us about cognitive impairment and dementia?
Narayanan, L., & Murray, A. D. (2016) · World Journal of Radiology · doi:10.4329/wjr.v8.i3.240 · Cited by 46
Evaluation of Cholinergic Deficiency in Preclinical Alzheimer’s Disease Using Pupillometry
Frost, S. M., Robinson, L., Rowe, C. C., Ames, D. J., Masters, C. L., Taddei, K., Rainey‐Smith, S. R., Martins, R. N., & Kanagasingam, Y. (2017) · Journal of Ophthalmology · doi:10.1155/2017/7935406 · Cited by 49
Disclosure of amyloid imaging results to research participants: Has the time come?
Lingler, J. H., & Klunk, W. E. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.09.014 · Cited by 44
Comparing Brain Amyloid Deposition, Glucose Metabolism, and Atrophy in Mild Cognitive Impairment with and without a Family History of Dementia
Mosconi, L., (ADNI), F. T. A. D. N. I., Andrews, R. D., & Matthews, D. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121867 · Cited by 41
Dementia and the Default Mode
Beason‐Held, L. L. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745294 · Cited by 43
The past, present, and future of disease-modifying therapies for Alzheimer’s disease
Suzuki, K., Iwata, A., & Iwatsubo, T. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.048 · Cited by 42
Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
Yuen, S. C., Liang, X., Zhu, H., Jia, Y., & Leung, S.-W. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00862-z · Cited by 42
The Role of Diffusion Tensor Imaging in the Study of Cognitive Aging
Carmichael, O. T., & Lockhart, S. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_176 · Cited by 46
Neuroimaging biomarkers for P arkinson disease: Facts and fantasy
Perlmutter, J. S., & Norris, S. A. (2014) · Annals of Neurology · doi:10.1002/ana.24291 · Cited by 41
Reliability and usability of an internet-based computerized cognitive testing battery in community-dwelling older people
Darby, D., Fredrickson, J., Pietrzak, R. H., Maruff, P. T., Woodward, M., & Brodtmann, A. G. (2013) · Computers in Human Behavior · doi:10.1016/j.chb.2013.08.009 · Cited by 43
Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment
Grill, J. D., Karlawish, J. H., Elashoff, D. A., & Vickrey, B. G. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.03.001 · Cited by 40
Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers
Roe, C. M., Ances, B. M., Head, D. M., Babulal, G. M., Stout, S. H., Grant, E., Hassenstab, J. J., Xiong, C., Holtzman, D. M., Benzinger, T. L. S., et al. (2018) · Brain · doi:10.1093/brain/awy244 · Cited by 42
Self-citation
Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
Shim, Y. S., & Morris, J. C. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.2.60 · Cited by 41
Self-citation
Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases
Campbell, M. C., Markham, J., Flores, H. P., Hartlein, J. M., Goate, A., Cairns, N. J., Videen, T. O., & Perlmutter, J. S. (2013) · Neurology · doi:10.1212/wnl.0b013e31829e6f94 · Cited by 39
Self-citation
Spectral Discrimination of Cerebral Amyloid Lesions after Peripheral Application of Luminescent Conjugated Oligothiophenes
Wegenast‐Braun, B. M., Skodras, A., Bayraktar, G., Mahler, J., Fritschi, S. K., Klingstedt, T., Mason, J. J., Hammarström, P., Nilsson, K. P. R., Liebig, C., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.08.031 · Cited by 38
Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment
Nosheny, R. L., Insel, P. S., Truran, D., Schuff, N. W., Jack, C. R., Aisen, P. S. S., Shaw, L. M. J., Trojanowski, J. Q., & Weiner, M. W. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.036 · Cited by 39
Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease
Hirao, K., Pontone, G. M., & Smith, G. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.010 · Cited by 38
Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
Öhrfelt, A., Andréasson, U., Simon, A. J., Zetterberg, H., Edman, Å., Potter, W. Z., Holder, D., Devanarayan, V., Seeburger, J. L., Smith, A. D., et al. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000323417 · Cited by 37
Filling the void: a role for exercise-induced BDNF and brain amyloid precursor protein processing
MacPherson, R. E. K. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00255.2017 · Cited by 41
Assessment of the mid-life demographic and lifestyle risk factors of dementia using data from the framingham heart study offspring cohort
Li, J., Ogrodnik, M., Kolachalama, V. B., Lin, H., & Au, R. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170917 · Cited by 36
Episodic Memory Decline Predicts Cortical Amyloid Status in Community-Dwelling Older Adults
Darby, D., Brodtmann, A. G., Pietrzak, R. H., Fredrickson, J., Woodward, M., Villemagne, V. L., Fredrickson, A., Maruff, P. T., & Rowe, C. C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110818 · Cited by 37
Imaging Epigenetics in Alzheimer’s Disease
Lista, S., Garaci, F. G., Toschi, N., & Hampel, H. J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990370 · Cited by 36
Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease
Mecca, A. P., Barcelos, N. M., Wang, S., Brück, A., Nabulsi, N., Planeta‐Wilson, B., Nadelmann, J. B., Benincasa, A. L., Ropchan, J. R., Huang, Y. H., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.027 · Cited by 40
In Vivo Human Amyloid Imaging
Sojkova, J., & Resnick, S. M. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745375 · Cited by 36
Staging Neurodegenerative Disorders: Structural, Regional, Biomarker, and Functional Progressions
Archer, T., Kostrzewa, R. M., Beninger, R. J., & Palomo, T. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9190-2 · Cited by 34
Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
Grill, J. D., Johnson, D. K., & Burns, J. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.75 · Cited by 36
Using Biomarkers to Improve Detection of Alzheimer’s Disease
Biagioni, M. C., & Galvin, J. E. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.11 · Cited by 35
Retina: Source of the Earliest Biomarkers for Alzheimer's Disease?
Krantic, S. M., & Torriglia, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132105 · Cited by 35
Exercise training and BDNF injections alter amyloid precursor protein (APP) processing enzymes and improve cognition
Baranowski, B. J., Mohammad, A., Finch, M. S., Brown, A. D. H., Dhaliwal, R., Marko, D. M., LeBlanc, P. J., McCormick, C. M., Fajardo, V. A., & MacPherson, R. E. K. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00114.2023 · Cited by 36
Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer’s Disease and Vascular Brain Injury
DeCarli, C. S., Villeneuve, S., Maillard, P., Harvey, D. J., Singh, B., Carmichael, O. T., Fletcher, E. M., Olichney, J., Farias, S. T., Jagust, W. J., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180965 · Cited by 33
In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease
Teipel, S. J., Dyrba, M., Chiesa, P. A., Sakr, F. A., Jelistratova, I., Lista, S., Vergallo, A., Lemercier, P., Cavedo, E., Habert, M. O., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.011 · Cited by 32
Neuropsychological correlates of instrumental activities of daily living in neurocognitive disorders: a possible role for executive dysfunction and mood changes
Amanzio, M., Palermo, S., Zucca, M., Rosato, R., Rubino, E., Leotta, D., Bartoli, M., & Rainero, I. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218000455 · Cited by 37
Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s Disease
Sutphen, C. L., Fagan, A. M., & Holtzman, D. M. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.031 · Cited by 31
Self-citation
Multimodal MRI ‐based imputation of the A β + in early mild cognitive impairment
Tosun, D., Joshi, S. C., Weiner, M. W., & Initiative, A. D. N. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.40 · Cited by 32
Amyloid imaging and memory change for prediction of cognitive impairment
Resnick, S. M., & Sojkova, J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt62 · Cited by 33
Use of Biomarkers in Clinical Trials of Alzheimer Disease
Wu, L., Rosa‐Neto, P., & Gauthier, S. G. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256467 · Cited by 32
Biomarkers in Alzheimer’s Disease
Riverol, M., & López, O. L. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00046 · Cited by 33
Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits
Smith, G. S., Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M. A., Gould, N. F., Savonenko, A. V., Coughlin, J. M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230570 · Cited by 31
Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment
Stevens, D. A., Workman, C. I., Kuwabara, H., Butters, M. A., Savonenko, A. V., Nassery, N., Gould, N. F., Kraut, M. A., Joo, J. H., Kilgore, J. J., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac016 · Cited by 32
Amyloid-β as a biomarker for Alzheimer’s disease: quantification methods in body fluids
Galozzi, S., Marcus, K., & Barkovits, K. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1065183 · Cited by 30
Sexual dimorphism of frailty and cognitive impairment: Potential underlying mechanisms
Ruan, Q., D’Onofrio, G., Wu, T., Greco, A., Sancarlo, D., & Yu, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6988 · Cited by 30
Nonfluent/Agrammatic PPA with In-Vivo Cortical Amyloidosis and Pick’s Disease Pathology
Caso, F., Gesierich, B. G., Henry, M. L., Sidhu, M., LaMarre, A. K., Babiak, M. C., Miller, B. L., Rabinovici, G. D., Huang, E. J., Magnani, G., et al. (2013) · Behavioural Neurology · doi:10.1155/2013/793530 · Cited by 31
Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults
Adamczuk, K., Weer, A. D., Nelissen, N., Dupont, P. J., Sunaert, S. G., Bettens, K., Sleegers, K., Broeckhoven, C. V., Laere, K. V., & Vandenberghe, R. R. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu286 · Cited by 32
Alzheimer disease: From biomarkers to diagnosis
Dubois, B., Epelbaum, S., Santos, A., Stefano, F. D., Julian, A. G., Michon, A., Sarazin, M., & Hampel, H. J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.016 · Cited by 34
Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease
Okonkwo, O. C., Oh, J. M., Koscik, R. L., Jonaitis, E. M., Cleary, C. A., Dowling, N. M., Bendlin, B. B., LaRue, A. A., Hermann, B. P., Barnhart, T. E., et al. (2014) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617714000113 · Cited by 31
Imaging Biomarkers in Alzheimer’s Disease: A Practical Guide for Clinicians
Sheikh‐Bahaei, N., Sajjadi, S. A., Manavaki, R., & Gillard, J. H. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170013 · Cited by 29
Perspectives for Multimodal Neurochemical and Imaging Biomarkers in Alzheimer's Disease
Teipel, S. J., Sabri, O., Grothe, M. J., Barthel, H., Prvulovic, D., Büerger, K., Bokde, A. L. W., Ewers, M., Hoffmann, W. U., & Hampel, H. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129030 · Cited by 27
Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar System
Steininger, S. C., Liu, X., Gietl, A. F., Wyss, M., Schreiner, S. J., Gruber, E., Treyer, V., Kälin, A. M., Leh, S. E., Buck, A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00052 · Cited by 27
Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Stella, F., & Gattaz, W. F. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-3505 · Cited by 31
The effect of beta‐amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal
Rieck, J. R., Rodrigue, K. M., Kennedy, K. M., Devous, M. D., & Park, D. C. (2015) · Human Brain Mapping · doi:10.1002/hbm.22788 · Cited by 26
Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye
Reed, B., Béhar‐Cohen, F., & Krantic, S. M. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160819131904 · Cited by 26
Quantitative Brain Amyloid PET
Jagust, W. J., Mattay, V. S., Krainak, D. M., Wang, S., Weidner, L. D., Hofling, A. A., Koo, H., Hsieh, P., Kuo, P. H., Farrar, G., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265766 · Cited by 25
Amyloid and Tau in Alzheimer’s Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?
Kumar, A., Nemeroff, C. B., Cooper, J. J., Widge, A. S., Rodríguez, C. I., Carpenter, L. L., & McDonald, W. M. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.19080873 · Cited by 25
The Reduction of Baseline Serotonin 2A Receptors in Mild Cognitive Impairment is Stable at Two-year Follow-up
Marner, L., Knudsen, G. M., Madsen, K., Holm, S., Baaré, W. F. C., & Hasselbalch, S. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100903 · Cited by 25
Recent Advances in Imaging Alzheimer's Disease
Braskie, M. N., Toga, A. W., & Thompson, P. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129016 · Cited by 26
Pupillary light reaction in preclinical Alzheimer’s disease subjects compared with normal ageing controls
Stavern, G. P. V., Bei, L., Shui, Y., Huecker, J. B., & Gordon, M. E. (2018) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-312425 · Cited by 25
Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults
Adamczuk, K., Weer, A. D., Nelissen, N., Dupont, P. J., Sunaert, S. G., Bettens, K., Sleegers, K., Broeckhoven, C. V., Laere, K. V., & Vandenberghe, R. R. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw117 · Cited by 24
A test of lens opacity as an indicator of preclinical Alzheimer Disease
Bei, L., Shui, Y., Bai, F., Nelson, S. K., Stavern, G. P. V., & Beebe, D. C. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.03.010 · Cited by 23
Social Networks, Community Engagement, and Cognitive Impairment among Community-Dwelling Chinese Older Adults
Li, J., Wang, Z., Lian, Z., Zhu, Z., & Liu, Y. (2019) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000502090 · Cited by 23
Early identification of Alzheimer's disease in mouse models: Application of deep neural network algorithm to cognitive behavioral parameters
Sutoko, S., Masuda, A., Kandori, A., Sasaguri, H., Saito, T., Saido, T. C., & Funane, T. (2021) · iScience · doi:10.1016/j.isci.2021.102198 · Cited by 23
Dementia screening, biomarkers and protein misfolding
Galvin, J. E. (2011) · Prion · doi:10.4161/pri.5.1.14439 · Cited by 23
Clearing the Amyloid in Alzheimer’s: Progress Towards Earlier Diagnosis and Effective Treatments – an Update for Clinicians
Asih, P. R., Chatterjee, P., Verdile, G., Gupta, V. B., Trengove, R. D., & Martins, R. N. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.29 · Cited by 24
Nonhuman primates at the intersection of aging biology, chronic disease, and health: An introduction to the American Journal of Primatology Special Issue on aging, cognitive decline, and neuropathology in nonhuman primates
Shively, C. A., Agnès Lacreuse, A., Frye, B. M., Rothwell, E. S., & Moro, M. (2021) · American Journal of Primatology · doi:10.1002/ajp.23309 · Cited by 24
Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults
Nosheny, R. L., Insel, P. S., Mattsson, N., Tosun, D., Buckley, S. T., Truran, D., Schuff, N. W., Aisen, P. S. S., & Weiner, M. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.005 · Cited by 23
Impact of Resilience on the Association Between Amyloid-β and Longitudinal Cognitive Decline in Cognitively Healthy Older Adults
Wolf, D. G. F., Initiative, A. D. N., Fischer, F. U., & Fellgiebel, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190370 · Cited by 21
Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers’ Risk of Alzheimer’s Disease
Mosconi, L., & McHugh, P. F. (2015) · Current Nutrition Reports · doi:10.1007/s13668-014-0111-5 · Cited by 22
Aducanumab and the “post-amyloid” era of Alzheimer research?
Musiek, E. S., & Bennett, D. A. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.007 · Cited by 20
Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease
Jia, K., Tian, J., Wang, T., Guo, L., Xuan, Z., Swerdlow, R. H., & Du, H. (2023) · JCI Insight · doi:10.1172/jci.insight.174290 · Cited by 20
Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease
Darby, D., Brodtmann, A. G., Woodward, M., Budge, M. M., & Maruff, P. T. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000354 · Cited by 19
A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas
Correa, D. D., Kryza‐Lacombe, M., Zhou, X., Baser, R. E., Beattie, B. J., Beiene, Z., Humm, J. L., DeAngelis, L. M., Orlow, I., Weber, W., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2692-5 · Cited by 19
Rostral-middle locus coeruleus integrity and subjective cognitive decline in early old age
Bell, T. R., Elman, J. A., Beck, A. I., Fennema‐Notestine, C., Gustavson, D. E., Hagler, D. J., Jak, A. J., Lyons, M. J., Puckett, O. K., Toomey, R., et al. (2022) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617722000881 · Cited by 19
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 21
Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression
Beckett, T. L., Webb, R. L., Niedowicz, D. M., Holler, C. J., Matveev, S., Baig, I., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120655 · Cited by 20
Driving and dementia: a clinician's guide
Wilson, S., & Pinner, G. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.111.009555 · Cited by 19
Molecular Neuroimaging in Alzheimer's Disease
Matsuda, H., & Imabayashi, E. (2011) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.005 · Cited by 21
Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model.
Malthankar‐Phatak, G. H., Lin, Y., Giovannone, N., & Siman, R. G. (2012) · Europe PMC (PubMed Central) · Cited by 18
Mild cognitive impairment
Gordon, C. A., & Martin, D. J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.856265 · Cited by 21
Choosing Alzheimer's disease prevention clinical trial populations
Grill, J. D., & Monsell, S. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.001 · Cited by 21
Multimodal Machine Learning for 10-Year Dementia Risk Prediction: The Framingham Heart Study
Ding, H., Mandapati, A., Hamel, A. P., Karjadi, C., Ang, T. F. A., Xia, W., Au, R., & Lin, H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230496 · Cited by 17

Authors: Morris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A.
Affiliations: Washington University in St. Louis (US)
ORCID: Morris, John C.
Roe, Catherine M.
Head, Denise
Goate, Alison M.
Fagan, Anne M.
Holtzman, David M.
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 2009-12-01
Volume: 66
Issue: 12
Pages: 1469-75
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneurol.2009.269
PMC: PMC2798814
OpenAlex: W2031489026
Cited by: 476
References: 57
Citations by year: 2026: 5 · 2025: 7 · 2024: 4 · 2023: 14 · 2022: 10 · 2021: 15 · 2020: 46 · 2019: 13 · 2018: 17 · 2017: 24 · 2016: 22 · 2015: 24 · 2014: 43 · 2013: 58 · 2012: 50
FWCI: 35.46
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (UL1TR000448)
National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991, P01AG026276)
National Center for Research Resources (UL1RR024992)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords: preclinical Alzheimer's disease, Pittsburgh compound B, amyloid PET, conversion to dementia, very mild dementia, cognitively normal older adults, Clinical Dementia Rating, episodic memory decline, visuospatial performance, entorhinal cortex, risk prediction
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Carbon Radioisotopes, Cognition, Cognition Disorders, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Predictive Value of Tests, Thiazoles, Cohort Studies, Disease Progression, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks